Despite some indicators of a localized curtailing of cardiovascular disease (CVD)
prevalence, CVD remains one of the largest contributors to global morbidity and mortality …

Cardiac rehabilitation has strong evidence of benefit across many cardiovascular conditions
but is underused. Even for those patients who participate in cardiac rehabilitation, there is …

Background Poor cardiovascular health (CVH) and physical frailty were reported to increase
mortality risk, but their joint effects have not been fully elucidated. Objectives We aimed to …

Background Metabolic dysfunction–associated fatty liver disease (MAFLD), defined as fatty
liver with overweight/obesity, type 2 diabetes, or metabolic abnormalities, is a newly …

To reduce morbidity and mortality rates of cardiovascular disease, an urgent need exists to
improve cardiovascular health among US adults. In 2022, the American Heart Association …

Aims The benefits of nationwide screening and tailored health guidance on improving
obesity and cardiovascular risk factors is uncertain. The aim of the present study was to …

Background There is currently a pervasive prevalence of cardiovascular disease (CVD) risk
worldwide and an inadequate amount of action is being taken to promote healthy lifestyle …

Background The role of the Mediterranean Diet (MD) in reducing cardiovascular (CV) risk is
widely demonstrated and many studies have shown the effectiveness of educational …

This meta-analysis aimed to summarise clinical evidence regarding the effect of
supplementation with cornelian cherry (Cornus mas L.) on different cardiometabolic …

Background: One aspect of the distancing measures imposed in response to the COVID-19
pandemic is that telemedicine consultations have increased exponentially. Among these …